Rahul Kumar Verma (Rahul K Verma)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

ACS biomaterials science & engineering

ACS applied bio materials

AAPS PharmSciTech

Biomacromolecules

Institute of Nano Science and Technology

Central Drug Research Institute (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Nano Science and Technology Jan 01 2017

India

Scientist D :: Nanobiotechnology

Institute of Nano Science and Technology Apr 07 2014 - Dec 31 2017

India

Scientist C :: Nanobiotechnology

University of Oklahoma Health Sciences Center Mar 01 2013 - Mar 30 2014

United States

Post Doctoral Fellow :: College of Pharmacy

Education History

Central Drug Research Institute Aug 14 2009 - Feb 22 2013

India

PHD :: Pharmaceutics

National Institute of Pharmaceutical Education and Research Jul 01 2003 - Jun 30 2005

India

MSC :: Biotechnology

Publications

Satyam Sharma, Moitrai Chakraborty, Dharmendra Yadav, Aniket Dhullap, Raghuraj Singh, Rahul Kumar Verma, Sankha Bhattacharya, Sanjiv Singh
Strategic Developments in Polymer-Functionalized Liposomes for Targeted Colon Cancer Therapy: An Updated Review of Clinical Trial Data and Future Horizons. Biomacromolecules (2024)
Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, Eupa Ray, Vimal Kumar, Awadh Bihari Yadav, Amit Kumar Singh, Rahul Kumar Verma
Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates. Nanoscale (2024)
Eupa Ray, Krishna Jadhav, Monika Kadian, Garima Sharma, Kritika Sharma, Agrim Jhilta, Raghuraj Singh, Anil Kumar, Rahul Kumar Verma
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies. Journal of materials chemistry. B (2024)
Satyam Sharma, Moitrai Chakraborty, Dharmendra Yadav, Aniket Dhullap, Raghuraj Singh, Rahul Kumar Verma, Sankha Bhattacharya, Sanjiv Singh
Strategic Developments in Polymer-Functionalized Liposomes for Targeted Colon Cancer Therapy: An Updated Review of Clinical Trial Data and Future Horizons. Biomacromolecules (2024)
Raghuraj Singh, Archna Panghal, Krishna Jadhav, Ashima Thakur, Rahul Kumar Verma, Charan Singh, Manoj Goyal, Jayant Kumar, Ajay G Namdeo
Recent Advances in Targeting Transition Metals (Copper, Iron, and Zinc) in Alzheimer's Disease. Molecular neurobiology (2024)
Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, Eupa Ray, Alok Kumar, Amit Kumar Singh, Rahul Kumar Verma
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression. ACS infectious diseases 10 (8) (2024)
Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, Eupa Ray, Alok Kumar, Amit Kumar Singh, Rahul Kumar Verma
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression. ACS infectious diseases (2024)
Ajit Singh, Rewati R Ujjwal, Saba Naqvi, Rahul Kumar Verma, Sanjay Tiwari, Prashant Kesharwani, Rahul Shukla
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease. Journal of drug targeting 30 (7) (2022)
Ajit Singh, Rewati Raman Ujjwal, Ashish Kumar, Rahul Kumar Verma, Rahul Shukla
Formulation and optimization of silymarin-encapsulated binary micelles for enhanced amyloid disaggregation activity. Drug development and industrial pharmacy 47 (11) (2022)
Kalpesh Vaghasiya, Ankur Sharma, Kushal Kumar, Eupa Ray, Suneera Adlakha, Om Prakash Katare, Sunil Kumar Hota, Rahul Kumar Verma
Correction to "Heparin Encapsulated Metered-Dose Topical 'Nano-Spray Gel' Liposomal Formulation Ensures Rapid On-Site Management of Frostbite Injury by Inflammatory Cytokines Scavenging". ACS biomaterials science & engineering 8 (6) (2022)
Anas Ahmad, Md Meraj Ansari, Rahul Kumar Verma, Rehan Khan
Aminocellulose-Grafted Polymeric Nanoparticles for Selective Targeting of CHEK2-Deficient Colorectal Cancer. ACS applied bio materials 4 (6) (2021)
Kalpesh Vaghasiya, Eupa Ray, Ankur Sharma, Om Prakash Katare, Rahul Kumar Verma
Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy. ACS applied bio materials 3 (8) (2020)
Arti Joshi, Ruby Gupta, Kalpesh Vaghasiya, Rahul Kumar Verma, Deepika Sharma, Monika Singh
In Vitro Anti-tumoral and Anti-bacterial Activity of an Octamolybdate Cluster-Based Hybrid Solid Incorporated with a Copper Picolinate Complex. ACS applied bio materials 3 (7) (2020)
Ankur Sharma, Kalpesh Vaghasiya, Eupa Ray, Pushpa Gupta, Umesh Datta Gupta, Amit Kumar Singh, Rahul Kumar Verma
Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of Mycobacterium tuberculosis by Enhancing the Autophagy and Suppressing Bacterial Burden. ACS biomaterials science & engineering 6 (7) (2020)
Eupa Ray, Kalpesh Vaghasiya, Ankur Sharma, Rahul Shukla, Rehan Khan, Anil Kumar, Rahul Kumar Verma
Autophagy-Inducing Inhalable Co-crystal Formulation of Niclosamide-Nicotinamide for Lung Cancer Therapy. AAPS PharmSciTech 21 (7) (2020)
Kalpesh Vaghasiya, Aisha Eram, Ankur Sharma, Eupa Ray, Suneera Adlakha, Rahul Kumar Verma
Alginate Microspheres Elicit Innate M1-Inflammatory Response in Macrophages Leading to Bacillary Killing. AAPS PharmSciTech 20 (6) (2019)
Kalpesh Vaghasiya, Ankur Sharma, Kushal Kumar, Eupa Ray, Suneera Adlakha, Om Prakash Katare, Sunil Kumar Hota, Rahul Kumar Verma
Heparin-Encapsulated Metered-Dose Topical "Nano-Spray Gel" Liposomal Formulation Ensures Rapid On-Site Management of Frostbite Injury by Inflammatory Cytokines Scavenging. ACS biomaterials science & engineering 5 (12) (2019)

Rahul Kumar Verma.css-eqlu8i{font-size:small;padding-left:4px;} (Rahul K Verma)

Publication Activity (10 Years)

Top Topics

Top Venues

Rahul Kumar Verma (Rahul K Verma)